{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:42:00Z","timestamp":1780476120054,"version":"3.54.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.reprotox.2016.11.002","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T16:31:44Z","timestamp":1478190704000},"page":"48-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Involvement of l-type amino acid transporter 1 in the transport of gabapentin into human placental choriocarcinoma cells"],"prefix":"10.1016","volume":"67","author":[{"given":"Ayako","family":"Furugen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Ishiguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Narumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Iseki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reprotox.2016.11.002_bib0005","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1528-1167.2006.00386.x","article-title":"Community-based prospective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy","volume":"47","author":"Viinikainen","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.reprotox.2016.11.002_bib0010","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(11)70107-7","article-title":"EURAP study group, Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry","volume":"10","author":"Tomson","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.reprotox.2016.11.002_bib0015","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(12)70323-X","article-title":"NEAD Study Group, Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study","volume":"12","author":"Meador","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.reprotox.2016.11.002_bib0020","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.reprotox.2016.11.002_bib0025","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/11536200-000000000-00000","article-title":"A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin","volume":"49","author":"Bockbrader","year":"2010","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.reprotox.2016.11.002_bib0030","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/epi.12711","article-title":"The efficacy of the newer antiepileptic drugs in controlling seizures in pregnancy","volume":"55","author":"Vajda","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.reprotox.2016.11.002_bib0035","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1212\/WNL.0b013e31828f18c1","article-title":"Pregnancy outcomes following gabapentin use: results of a prospective comparative cohort study","volume":"80","author":"Fujii","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.reprotox.2016.11.002_bib0040","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.pediatrneurol.2015.06.023","article-title":"Neonatal gabapentin withdrawal syndrome","volume":"53","author":"Carrasco","year":"2015","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.reprotox.2016.11.002_bib0045","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/j.1528-1167.2005.00251.x","article-title":"Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation: does a fetal accumulation occur during pregnancy?","volume":"46","author":"Ohman","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.reprotox.2016.11.002_bib0050","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.bcp.2013.03.022","article-title":"Transport of gabapentin by LAT1 (SLC7A5)","volume":"85","author":"Dickens","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.reprotox.2016.11.002_bib0055","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jchromb.2015.08.031","article-title":"Quantification of new antiepileptic drugs by liquid chromatography\/electrospray ionization tandem mass spectrometry and its application to cellular uptake experiment using human placental choriocarcinoma BeWo cells","volume":"1002","author":"Furugen","year":"2015","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.reprotox.2016.11.002_bib0060","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/sj.clpt.6100271","article-title":"Effects of genetic variation in the novel organic cation transporter OCTN1, on the renal clearance of gabapentin","volume":"83","author":"Urban","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.reprotox.2016.11.002_bib0065","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s11095-014-1505-1","article-title":"In vivo and in vitro evaluations of intestinal gabapentin absorption: effect of dose and inhibitors on carrier-mediated transport","volume":"32","author":"Larsen","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.reprotox.2016.11.002_bib0070","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.mam.2012.10.007","article-title":"The SLC3 and SLC7 families of amino acid transporters","volume":"34","author":"Fotiadis","year":"2013","journal-title":"Mol. Aspects Med."},{"issue":"Suppl. 1","key":"10.1016\/j.reprotox.2016.11.002_bib0075","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/1756-6614-4-S1-S7","article-title":"Primary and secondary thyroid hormone transporters","volume":"4","author":"Kinne","year":"2011","journal-title":"Thyroid Res."},{"key":"10.1016\/j.reprotox.2016.11.002_bib0080","doi-asserted-by":"crossref","first-page":"23629","DOI":"10.1074\/jbc.273.37.23629","article-title":"Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98)","volume":"273","author":"Kanai","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.reprotox.2016.11.002_bib0085","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/bdd.1816","article-title":"Pharmacological and pathophysiological roles of carnitine\/organic cation transporters (OCTNs: SLC22A4 SLC22A5 and Slc22a21)","volume":"34","author":"Tamai","year":"2013","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.reprotox.2016.11.002_bib0090","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s11095-007-9254-z","article-title":"Polyspecific organic cation transporters: structure function, physiological roles, and biopharmaceutical implications","volume":"24","author":"Koepsell","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.reprotox.2016.11.002_bib0095","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.tiv.2012.08.027","article-title":"Placental transfer and metabolism: an overview of the experimental models utilizing human placental tissue","volume":"27","author":"Myllynen","year":"2013","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.reprotox.2016.11.002_bib0100","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring ILAE Commission on Therapeutic Strategies","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.reprotox.2016.11.002_bib0105","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0076-6879(79)55066-6","article-title":"The measurement of membrane potential and deltapH in cells, organelles, and vesicles","volume":"55","author":"Rottenberg","year":"1979","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.reprotox.2016.11.002_bib0110","doi-asserted-by":"crossref","first-page":"22141","DOI":"10.1074\/jbc.M109.084426","article-title":"A novel transporter of SLC22 family specifically transports prostaglandins and co-localizes with 15-hydroxyprostaglandin dehydrogenase in renal proximal tubules","volume":"285","author":"Shiraya","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.reprotox.2016.11.002_bib0115","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1021\/mp900206j","article-title":"Transport of ipratropium, an anti-chronic obstructive pulmonary disease drug, is mediated by organic cation\/carnitine transporters in human bronchial epithelial cells: implications for carrier-mediated pulmonary absorption","volume":"7","author":"Nakamura","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.reprotox.2016.11.002_bib0120","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3109\/1061186X.2012.716847","article-title":"Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure","volume":"20","author":"Staud","year":"2012","journal-title":"J. Drug Target"},{"key":"10.1016\/j.reprotox.2016.11.002_bib0125","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.pain.2010.06.019","article-title":"The evidence for pharmacological treatment of neuropathic pain","volume":"150","author":"Finnerup","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.reprotox.2016.11.002_bib0130","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11940-014-0317-2","article-title":"Restless legs syndrome: pathophysiology and treatment","volume":"16","author":"Ondo","year":"2014","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.reprotox.2016.11.002_bib0135","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/jphp.12574","article-title":"L503F variant of carnitine\/organic cation transporter 1 efficiently transports metformin and other biguanides","volume":"68","author":"Futatsugi","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.reprotox.2016.11.002_bib0140","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1210\/endo.142.10.8418","article-title":"Thyroid hormone transport by the heterodimeric human system L amino acid transporter","volume":"142","author":"Friesema","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.reprotox.2016.11.002_bib0145","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.placenta.2014.11.001","article-title":"Drug transporter expression during in vitro differentiation of first-trimester and term human villous trophoblasts","volume":"36","author":"Berveiller","year":"2015","journal-title":"Placenta"},{"key":"10.1016\/j.reprotox.2016.11.002_bib0150","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0022-3565(24)38199-6","article-title":"A Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations","volume":"289","author":"Yabuuchi","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.reprotox.2016.11.002_bib0155","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijpharm.2007.09.022","article-title":"The inhibitory effects of fluoroquinolones on L-carnitine transport in placental cell line BeWo","volume":"351","author":"Hirano","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.reprotox.2016.11.002_bib0160","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1124\/jpet.104.072363","article-title":"Novel organic cation transporter 2-mediated carnitine uptake in placental choriocarcinoma (BeWo) cells","volume":"312","author":"Rytting","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.reprotox.2016.11.002_bib0165","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12958-015-0054-8","article-title":"Expression and functional characterisation of System L amino acid transporters in the human term placenta","volume":"13","author":"Gaccioli","year":"2015","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.reprotox.2016.11.002_bib0170","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1742-7843.2010.00634.x","article-title":"In vitro approaches to evaluate placental drug transport by using differentiating JEG-3 human choriocarcinoma cells","volume":"108","author":"Ikeda","year":"2011","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.reprotox.2016.11.002_bib0175","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cell.2008.11.044","article-title":"Bidirectional transport of amino acids regulates mTOR and autophagy","volume":"136","author":"Nicklin","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.reprotox.2016.11.002_bib0180","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/emboj\/21.4.580","article-title":"Activation of system L heterodimeric amino acid exchangers by intracellular substrates","volume":"21","author":"Meier","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.reprotox.2016.11.002_bib0185","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/epi.13037","article-title":"Antiepileptic drugs alter the expression of placental carriers: an in vitro study in a human placental cell line","volume":"56","author":"Rubinchik-Stern","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.reprotox.2016.11.002_bib0190","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.bbmt.2014.03.022","article-title":"A single nucleotide polymorphism in SLC7A5 is associated with gastrointestinal toxicity after high-dose melphalan and autologous stem cell transplantation for multiple myeloma","volume":"20","author":"Giglia","year":"2014","journal-title":"Biol. Blood Marrow Transplant"}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623816303926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623816303926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:42:35Z","timestamp":1760190155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623816303926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":38,"alternative-id":["S0890623816303926"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2016.11.002","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of l-type amino acid transporter 1 in the transport of gabapentin into human placental choriocarcinoma cells","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2016.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}